Maria Palasis
Amministratore Delegato presso LYRA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Dr. Maria Palasis is a President, Chief Executive Officer & Director at Lyra Therapeutics, Inc. She is on the Board of Directors at Beta Bionics, Inc., Lyra Therapeutics, Inc., Medexecwomen and PanTher Therapeutics, Inc. Dr. Palasis was previously employed as a President, Chief Executive Officer & Director by Arsenal Medical, Inc. She also served on the board at Boston Scientific Corp.
She received her undergraduate degree from the University of Cincinnati (Ohio) and a doctorate degree from the University of Cincinnati (Ohio).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LYRA THERAPEUTICS, INC.
-.--% | 03/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Maria Palasis
| Società | Posizione | Inizio |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Amministratore Delegato | 01/01/2015 |
PanTher Therapeutics, Inc.
 PanTher Therapeutics, Inc. Medical/Nursing ServicesHealth Services PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
| Medexecwomen | Direttore/Membro del Consiglio | - |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 01/01/2022 |
Precedenti posizioni note di Maria Palasis
| Società | Posizione | Fine |
|---|---|---|
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Amministratore Delegato | 01/06/2018 |
| BOSTON SCIENTIFIC CORPORATION | Direttore/Membro del Consiglio | 01/01/2008 |
Formazione di Maria Palasis
| University of Cincinnati (Ohio) | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Arsenal Medical, Inc.
Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Commercial Services |
PanTher Therapeutics, Inc.
PanTher Therapeutics, Inc. Medical/Nursing ServicesHealth Services PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA. | Health Services |
| Medexecwomen | |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Maria Palasis
